Warnex Inks Deal with Canada to Develop Forensic Mitochondrial Pre-screen | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Warnex Pro-DNA Services today announced a contribution agreement with Canada's federal research and development organization to develop a pre-screening method for forensic mitochondrial DNA testing.

Under the deal, the National Research Council of Canada Industrial Research Assistance Program will provide Warnex Pro-DNA up to C$49,200 (US$48,000) in funding, as well as technical and business advisory services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.